January 24, 2017
Nicox to test new eye drug
Nicox, the international ophthalmic R&D company, has provided certain regulatory and clinical updates for NCX 470, its novel nitric oxide…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
January 24, 2017
Exclusive: Canada seeks warnings on prescription painkillers amid rising deaths
As deaths from powerful painkillers continue to rise, Canada is pursuing unprecedented measures to curb their use, including requiring cigarette-style warning stickers on every prescription, Health Minister Jane Philpott told Reuters.
January 24, 2017
Asit’s Phase II study of dust allergy treatment shows success
Asit biotech has completed Phase IIa double-blind placebo-controlled clinical study in house dust mite-induced rhinoconjunctivitis.
January 24, 2017
Abzena to issue ordinary shares
Abzena has made application to the London Stock Exchange for the admission of 715,772 new ordinary shares of £0.002 each (‘New Ordinary Shares’) to trading on AIM.
January 24, 2017
Short: Van Herk Investments announces 10.07% Shareholding in Ablynx
Van Herk Investments B.V. has become owner of more than 10% of Ablynx as it has crossed the 10% threshold and now…
January 24, 2017
Vectura starts with testing asthma drug/device combination for children
Vectura Group is moving on with researching and testing its VR647, a drug/device combination to treat asthma in children for the US market.
January 24, 2017
Advanced Oncotherapy to take “appropriate action” against Sinophi Healthcare
Advanced Oncotherapy said on Tuesday it will “appropriately” deal with a UK company Sinophi Healthcare, which invests in and manages hospitals in China, because it wanted to drop purchase orders made two years ago.
January 24, 2017
ImmuPharma appoints new adviser
ImmuPharma has appointed Northland Capital Partners as its Nominated Adviser and sole broker with immediate effect. ImmuPharma is a pharmaceutical…
January 23, 2017
Swedish Oasmia targets $16B worth US animal health care market
A swedish oncology company Oasmia Pharmaceutical AB, which works on finding cancer cures for animals and humans, said it would move its veterinary assets to the United States.
January 23, 2017
BD’s PleurX cleared for recurrent pleural effusions in USA
BD (Becton, Dickinson) has received the U.S. Food and Drug Administration (FDA) 510(k) clearance for the use of PleurX catheter system in certain problems like heart failure.